Glenmede Trust Co. NA Reduces Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Glenmede Trust Co. NA cut its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 42.2% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 38,910 shares of the company’s stock after selling 28,439 shares during the period. Glenmede Trust Co. NA owned approximately 0.07% of Molina Healthcare worth $13,407,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Innealta Capital LLC purchased a new stake in shares of Molina Healthcare during the second quarter valued at approximately $36,000. Ashton Thomas Private Wealth LLC purchased a new stake in Molina Healthcare during the 2nd quarter worth $40,000. AM Squared Ltd purchased a new stake in Molina Healthcare during the 2nd quarter worth $59,000. Capital Performance Advisors LLP acquired a new position in Molina Healthcare in the 3rd quarter worth $62,000. Finally, UMB Bank n.a. boosted its position in Molina Healthcare by 96.2% in the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after buying an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MOH. Wells Fargo & Company boosted their price target on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research note on Monday, November 4th. Barclays upped their price target on shares of Molina Healthcare from $359.00 to $372.00 and gave the company an “equal weight” rating in a report on Friday, October 25th. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, October 24th. StockNews.com raised shares of Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. Finally, Robert W. Baird reduced their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $367.17.

Molina Healthcare Price Performance

NYSE MOH opened at $296.60 on Friday. The company has a 50-day moving average price of $319.53 and a two-hundred day moving average price of $322.75. The stock has a market cap of $16.97 billion, a price-to-earnings ratio of 15.06, a price-to-earnings-growth ratio of 1.03 and a beta of 0.59. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. Molina Healthcare, Inc. has a 52 week low of $272.69 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.96 by $0.05. The business had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. The business’s revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period in the prior year, the company posted $5.05 EPS. Analysts forecast that Molina Healthcare, Inc. will post 23.44 EPS for the current year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.